OpenAlex
PricingAboutJobs
Log inGet started
Work

A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life

HTML

Year: 2010
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-09-4580
Authors: Yik Andy Yeung, Xiumin Wu, Arthur E. Reyes, Jean-Michel Vernes, Samantha Lien, John Lowe, Mauricio Maia, William F. Forrest, Y. Gloria Meng, Lisa A. Damico, Napoleone Ferrara, Henry B. Lowman
Institution: Genentech
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: bevacizumab, anti-VEGF antibody, neonatal Fc receptor, antibody engineering, anti-angiogenic therapy, dosing frequency, antibody potency, tumor xenograft models
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2113701404
FWCI: 3.984
Cites: 42
Cited by: 84
Related to: 10
Parts: 15
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security